MedPath

Clinical trials to evaluate the effectiveness of lingonberry and amla fruit extract intake

Not Applicable
Conditions
The healthy female who feels decline of the skin condition
Registration Number
JPRN-UMIN000031682
Lead Sponsor
SHISEIDO CO., LTD.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Female
Target Recruitment
90
Inclusion Criteria

Not provided

Exclusion Criteria

1.Individuals with abnormalities of skin areas planned to be tested 2.Individuals considered likely to develop allergy to the test substance (Individuals with food allergy) 3.Individuals with chronic cutis symptoms such as atopic dermatitis 4.Patients receiving drug therapy as outpatients 5.Individuals participating in other studies within the past 3 months 6.Habitual smokers 7.Patients with asthma 8.Pregnant women, women desiring to become pregnant, or lactating women 9.Individuals having used cosmetics or the like possessing moisture-retaining effects on the skin areas planned to be tested in this study within 1 month before the start of the study 10.Individuals taking or intending to take drugs against pollinosis 11.Individuals judged inappropriate for the study by attending physician

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The elasticity of the skin is measured four times for 12 weeks every four weeks.
Secondary Outcome Measures
NameTimeMethod
The following measurement item is measured four times for 12 weeks every four weeks. 1. Skin thickness 2. Stratum corneum hydration 3. Epidermal and dermal hydration 4. Clinical evaluation of wrinkle
© Copyright 2025. All Rights Reserved by MedPath